Trial intelligence / Profile preview

SJP-001 for the Prevention of Alcohol Hangover

NCT07487909Phase 2Completed

Sponsor
Sen-Jam Pharmaceutical
Start
Sep 2025
Primary completion
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of SJP-001 in alcohol hangover, sponsored by Sen-Jam Pharmaceutical. Started Sep 2025; status: completed.

02

Drugs

SJP-001
03

Conditions

alcohol hangover

Beyond the preview

Go deeper on NCT07487909.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07487909.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call